Blogs & Articles

Industry Trends
Breaking Through Synthesis Challenges: Hongene Accelerates Clinical Translation of Dual-Targeting Oligonucleotide Drugs!
NEWS On September 9, 2024, ReciBioPharm, a US-based contract development and manufacturing organization (CDMO) service provider, and Hongene Biotech, a leading supplier in the nucleic acid raw materials field, announced...
Industry Trends
Ushering in a New Era of Lipid Management – Hongene Empowers Oligo Theraputics to Expand into Metabolic Diseases
Hypercholesterolemia is one of the most common chronic metabolic disorders. Its core characteristic is abnormally elevated levels of "bad cholesterol," or low-density lipoprotein cholesterol (LDL-C), which can form atherosclerotic plaques...

How can we help you?

Product/Price Inquiry

Custom Request

Others

This contact form is related to product inquiries. Please visit a product page to see specific product information.

Message

Name

Company

Phone

City

Country

Product Center